GAMA
PBYI icon

Graticule Asia Macro Advisors’s Puma Biotechnology PBYI Stock Holding History

Graticule Asia Macro Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-40,210
Closed -$3.51M – 126
2017
Q2 		$3.51M Sell
40,210
-6,200
-13% -$347K 0.44% 79
2017
Q1 		$1.73M Buy
46,410
+21,410
+86% +$781K 0.17% 103
2016
Q4 		$768K Buy
25,000
+3,138
+14% +$136K 0.16% 88
2016
Q3 		$1.47M Buy
+21,862
New +$1.11M 0.28% 73
2016
Q1 		– Sell
-26,700
Closed -$2.09M – 172
2015
Q4 		$2.09M Buy
26,700
+6,700
+34% +$526K 0.45% 49
2015
Q3 		$1.51M Buy
+20,000
New +$1.89M 0.37% 62

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return